Your browser doesn't support javascript.
loading
Modifiable risk factors associated with cardiovascular disease and mortality in China: a PURE substudy.
Li, Sidong; Liu, Zhiguang; Joseph, Philip; Hu, Bo; Yin, Lu; Tse, Lap Ah; Rangarajan, Sumathy; Wang, Chuangshi; Wang, Yang; Islam, Shofiqul; Liu, Weida; Lu, Fanghong; Li, Yindong; Hou, Yan; Qiang, Deren; Zhao, Qian; Li, Ning; Lei, Rensheng; Chen, Di; Han, Aiying; Liu, Guoqin; Zhang, Peng; Zhi, Yahong; Liu, Chunmei; Yang, Jinkui; Resalaiti, Aobulikasimu; Ma, Haibin; Ma, Yuanting; Liu, Yu; Xing, Xiaojie; Xiang, Quanyong; Liu, Zhengrong; Sheng, Yundong; Tang, Jinghua; Liu, Lisheng; Yusuf, Salim; Li, Wei.
Afiliação
  • Li S; Medical Research and Biometrics Center, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Liu Z; Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
  • Joseph P; Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, Ontario, Canada.
  • Hu B; Medical Research and Biometrics Center, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Yin L; Medical Research and Biometrics Center, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Tse LA; Division of Occupational and Environmental Health, Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong, China.
  • Rangarajan S; Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, Ontario, Canada.
  • Wang C; Medical Research and Biometrics Center, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Wang Y; Medical Research and Biometrics Center, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Islam S; Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, Ontario, Canada.
  • Liu W; Medical Research and Biometrics Center, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Lu F; Shandong Academy of Medical Sciences, Basic Medical Institute, Jinan, China.
  • Li Y; Shunyi District Center for Disease Control and Prevention, Beijing, China.
  • Hou Y; Balingqiao Community Health Service Center, Taiyuan, China.
  • Qiang D; Wujin District Center for Disease Control and Prevention, Changzhou, China.
  • Zhao Q; West China Hospital of Sichuan University, Chengdu, China.
  • Li N; Qingshanhu Community Health Service Station, Nanchang, China.
  • Lei R; Center for Disease Control and Prevention of Nanchang County, Nanchang, China.
  • Chen D; Jishuitan Hospital, Beijing, China.
  • Han A; Bayannaoer Center for Disease Control and Prevention, Bayannaoer, China.
  • Liu G; Jingle People's Hospital, Xinzhou, China.
  • Zhang P; Health Center of Guanshan Town, Xi'an, China.
  • Zhi Y; Hospital of Xi'an University of Electronic Science and Technology, Xi'an, China.
  • Liu C; Mengla District Center for Disease Control and Prevention, Xishuangbanna, China.
  • Yang J; Central hospitals of Menglong District, Xishuangbanna, China.
  • Resalaiti A; Hetian Center for Disease Control and Prevention, Hetian, China.
  • Ma H; Xining Center for Disease Control and Prevention, Xining, China.
  • Ma Y; Xining east area of Dongguan Street Community Health Service Center, Xining, China.
  • Liu Y; 242 Hospital, Shenyang, China.
  • Xing X; The Red Cross hospital of Shenyang, Shenyang, China.
  • Xiang Q; Jiangsu Centers for Disease Control and Prevention, Nanjing, China.
  • Liu Z; Jiangxinzhou Community Health Service Center, Nanjing, China.
  • Sheng Y; Jiangxinzhou Community Health Service Center, Nanjing, China.
  • Tang J; Xiaohang Hospital, Nanjing, China.
  • Liu L; Beijing Hypertension League Institute, Beijing, China.
  • Yusuf S; Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, Ontario, Canada.
  • Li W; Medical Research and Biometrics Center, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Eur Heart J ; 43(30): 2852-2863, 2022 08 07.
Article em En | MEDLINE | ID: mdl-35731140
ABSTRACT

AIMS:

To examine the incidence of cardiovascular disease (CVD) and mortality in China and in key subpopulations, and to estimate the population-level risks attributable to 12 common modifiable risk factors for each outcome. METHODS AND

RESULTS:

In this prospective cohort of 47 262 middle-aged participants from 115 urban and rural communities in 12 provinces of China, it was examined how CVD incidence and mortality rates varied by sex, by urban-rural area, and by region. In participants without prior CVD, population-attributable fractions (PAFs) for CVD and for death related to 12 common modifiable risk factors were assessed four metabolic risk factors (hypertension, diabetes, abdominal obesity, and lipids), four behavioural risk factors (tobacco, alcohol, diet quality, and physical activity), education, depression, grip strength, and household air pollution. The mean age of the cohort was 51.1 years. 58.2% were female, 49.2% were from urban areas, and 59.6% were from the eastern region of China. The median follow-up duration was 11.9 years. The CVD was the leading cause of death in China (36%). The rates of CVD and death were 8.35 and 5.33 per 1000 person-years, respectively, with higher rates in men compared with women and in rural compared with urban areas. Death rates were higher in the central and western regions of China compared with the eastern region. The modifiable risk factors studied collectively contributed to 59% of the PAF for CVD and 56% of the PAF for death in China. Metabolic risk factors accounted for the largest proportion of CVD (PAF of 41.7%), and hypertension was the most important risk factor (25.0%), followed by low education (10.2%), high non-high-density lipoprotein cholesterol (7.8%), and abdominal obesity (6.9%). The largest risk factors for death were hypertension (10.8%), low education (10.5%), poor diet (8.3%), tobacco use (7.5%), and household air pollution (6.1%).

CONCLUSION:

Both CVD and mortality are higher in men compared with women, and in rural compared with urban areas. Large reductions in CVD could potentially be achieved by controlling metabolic risk factors and improving education. Lowering mortality rates will require strategies addressing a broader range of risk factors.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Hipertensão Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: Eur Heart J Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Hipertensão Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: Eur Heart J Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China